CPT code 81248: G6PD testing, known familial variant2026 Medicare lab fee · Clinical Laboratory Fee Schedule
Targeted genetic testing identifies a previously established familial G6PD variant when evaluating inherited deficiency or a family-specific risk.
Medicare pays $375.25 for 81248 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.
Medicare lab fee · CLFS 2026 Q4
National CLFS amount
$375.25
In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.
- Geographic adjustment
- None
- Office vs facility
- Same
- Since 2020
- Unchanged
- CMS updates
- Quarterly
Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.
On this page 8 sections
What 81248 covers
This molecular test analyzes the G6PD gene for a variant already identified in the family. Clinicians may order it when investigating suspected inherited G6PD-related hemolytic anemia or jaundice, or to assess whether a relative carries the known familial variant. The laboratory performs the genetic analysis; the result is specific to the familial variant being assessed, rather than a broad search across the gene.
Report this code for analysis of a known familial G6PD variant, not for common-variant testing or full-gene sequencing. Medicare pays the test through the Clinical Laboratory Fee Schedule (CLFS), at one national amount across localities and with no office-versus-facility difference. The 2026 national CLFS amount is $375.25, unchanged since 2020. The test is excluded from the physician fee schedule by statute and paid through the CLFS.
This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.
How Medicare pays 81248
Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.
One national amount
CMS sets a single Clinical Laboratory Fee Schedule amount for 81248. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.
No office or facility rate
Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.
Updated every quarter
CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.
Excluded from the physician fee schedule
The physician fee schedule lists 81248 with status X (excluded by statute), so the test itself is paid only from the CLFS.
81248 on the lab fee schedule since 2020
81248 · CLFS 2026 Q4 (current)
$375.25
Unchanged since Jan 1, 2020
27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.
81248 compared with similar tests
- 81247G6PD gene testCommon-variant analysis$174.81
- Choose 81248 when the specific familial G6PD variant is known and targeted. Code 81247 addresses common G6PD variants.
- 81249G6PD sequencingFull gene sequence$600.00
- Code 81248 targets a known familial variant; 81249 reports full-gene sequencing.
- 82955G6PD assayQuantitative enzyme activity$9.70
- Code 82955 measures G6PD enzyme activity. Code 81248 analyzes the gene for a known familial variant.
81248 billing questions
When should this code be chosen over G6PD common-variant testing?
Use this code when testing targets a G6PD variant already identified in the family. Common-variant testing is a different scope of analysis.
How does this differ from G6PD full-gene sequencing?
This code represents targeted analysis for a known familial variant. Full-gene sequencing examines the gene more broadly.
Is this the same as a G6PD enzyme activity test?
No. This code reports genetic analysis for a known familial variant; code 82955 measures G6PD enzyme activity.
How does Medicare pay for this test?
Medicare pays it through the CLFS at one national amount across localities, with no office-versus-facility difference. The test is excluded from the physician fee schedule by statute.
What should documentation identify for this test?
Documentation should identify the known familial G6PD variant targeted by the analysis.
Where this amount comes from
FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.
CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027
Show the CMS file line behind this amount
Fee sheets · Coming soon
Put 81248 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist